Arfendazam
From Drugwiki - Information about drugs, steroids and medicine
| |
| Arfendazam
| |
| Systematic (IUPAC) name | |
| ethyl 7-chloro- 4-oxo- 5-phenyl- 2,3-dihydro- 1,5-benzodiazepine- 1-carboxylate | |
| Identifiers | |
| CAS number | |
| ATC code | none |
| PubChem | |
| Chemical data | |
| Formula | C18H17ClN2O3 |
| Mol. mass | 344.792 |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Arfendazam is a drug which is a benzodiazepine derivative. Arfendazam is a 1,5-benzodiazepine, with the nitrogen atoms located at positions 1 and 5 of the diazepine ring, and so is most closely related to other 1,5-benzodiazepines such as clobazam. Arfendazam has sedative and anxiolytic effects similar to those produced by other benzodiazepine derivatives, but is a partial agonist at GABAA receptors, so the sedative effects are relatively mild and it produces muscle relaxant effects only at very high doses. Arfendazam produces an active metabolite lofendazam, which is thought to be responsible for part of its effects.